Vital Chemtech Mukeshkumar Kanazariya as Non appointed
Vital Chemtech (VITAL) said Mukeshkumar Kanazariya as Non has been appointed. The company is valued at about ₹117 crore.
What happened
In a filing with the NSE on 2 November 2026 at 05:47 PM, Vital Chemtech (VITAL) said that Mukeshkumar Kanazariya as Non has been appointed.
From the filing: "Vital Chemtech Limited has informed the Exchange regarding Appointment of Mr."
Company snapshot
Vital Chemtech is a micro-cap company, with a market value of about ₹117 crore.
The stock last traded at ₹49, against a 52-week range of ₹35.4–₹69.4 (29.4% below the high).
Before this filing the shares had moved −5.4% over the month and +7.4% over three months. Average daily turnover over the last 20 sessions was about ₹0.02 crore.
Promoters held 73.43% at the end of Q1 FY27. Foreign institutions owned 1.62% and domestic institutions 0.25%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q4 FY25 | 68 | 1.7 | 0.73 |
| Q2 FY26 | 65 | 1.4 | 0.57 |
| Q4 FY26 | 35 | 0.8 | 0.36 |
| Q1 FY27 | 51 | 2.5 | 1.08 |
What history shows
BCEIE's records show 5 previous management change filings from the company since May 2026.
After those filings, the stock fell 6.2% on average the next trading day and was down 0.7% on average after five days (5 filings with price data).
Market-wide, 4,084 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 30 Sept 2026 | Re-Appointment of Mr. Jay Bhatt as Whole Time Director of the… | −5.3% | — |
| 30 Sept 2026 | Re-Appointment of Mr. Vipul Bhatt as Chairman & Managing Director of… | −5.3% | — |
| 14 Aug 2026 | Resignation of Mr Vipul Bhatt as Chief Financial Officer of the… | −5.8% | −1.3% |
| 14 Aug 2026 | Appointment of Mr Jitendra Raval as Chief Financial Officer of the… | −5.8% | −1.3% |
| 29 May 2026 | Appointment of M/s R J & Associates as Cost Auditor of the company… | −8.5% | +0.5% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 2 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.